Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

AAdaptimmune Therapeutics PLC

EconomyAI buildoutMarket MapFundsWatchlist
Log in
A

Adaptimmune Therapeutics PLC

$0.02Close · Oct 6, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $13.68M. Net result −$30.34M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $13.68M. Running result $13.68M. Development Revenue: $2.6M. Product: $11.08M.
  • Cost of revenue: −$2.5M. Running result $11.18M.
  • Gross profit: $11.18M. Running result $11.18M.
  • Research and development: −$22.98M. Running result −$11.8M.
  • Selling, general and administrative: −$18.49M. Running result −$30.29M.
  • Operating income: −$30.29M. Running result −$30.29M.
  • Other income: $560K. Running result −$29.73M.
  • Pre-tax loss: −$29.73M. Running result −$29.73M.
  • Income tax expense: −$612K. Running result −$30.34M.
  • Net loss: −$30.34M. Running result −$30.34M.